The global cardiometabolic diseases market is witnessing steady expansion driven by the rising prevalence of cardiovascular disease, type 2 diabetes, obesity, and hypertension—conditions that are increasingly interconnected under the cardiometabolic spectrum. According to industry estimates, the market is projected to grow from US$ 109.28 billion in 2025 to US$ 155.56 billion by 2034 ,...